| 1 |
34929248 | Niclosamide inhibits hepatitis E virus through suppression of NF-kappaB signalling. | 2022 Jan |
3 |
| 2 |
33524445 | Chemical mitochondrial uncouplers share common inhibitory effect on NLRP3 inflammasome activation through inhibiting NFκB nuclear translocation. | 2021 Mar 1 |
3 |
| 3 |
31950153 | Niclosamide suppresses macrophage-induced inflammation in endometriosis†. | 2020 Apr 24 |
2 |
| 4 |
31623154 | The S100A4 Transcriptional Inhibitor Niclosamide Reduces Pro-Inflammatory and Migratory Phenotypes of Microglia: Implications for Amyotrophic Lateral Sclerosis. | 2019 Oct 16 |
2 |
| 5 |
28389414 | Niclosamide: Beyond an antihelminthic drug. | 2018 Jan |
1 |
| 6 |
27127879 | S100A4 drives non-small cell lung cancer invasion, associates with poor prognosis, and is effectively targeted by the FDA-approved anti-helminthic agent niclosamide. | 2016 Jun 7 |
1 |
| 7 |
26716739 | [Molecular mechanisms of niclosamide antitumor activity]. | 2015 Nov-Dec |
1 |
| 8 |
24732808 | Multi-targeted therapy of cancer by niclosamide: A new application for an old drug. | 2014 Jul 10 |
1 |
| 9 |
22237038 | Niclosamide, an old antihelminthic agent, demonstrates antitumor activity by blocking multiple signaling pathways of cancer stem cells. | 2012 Apr |
1 |